Skip to main
TFX

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 50%
Hold 38%
Sell 0%
Strong Sell 0%

Bulls say

Teleflex is a growing medical technology company with strong financial performance and a commitment to shareholder value. Although there may be some challenges in the near term, the company's focus on sustainable growth and cost savings, as well as strategic M&A and returning cash to shareholders, suggest a positive outlook for the company's stock. The potential for divestitures and a diverse product portfolio also adds to the long-term growth potential for investors.

Bears say

Teleflex is facing potential downside risks, as the company's plans to unlock value through a spin-off or sale of several business lines may not go as planned. Additionally, there may be challenges in executing the company's growth and margin profile assumptions, leading to limited upside potential. The recent portfolio moves, including acquisitions and divestitures, could result in uncertainty in the near-to-intermediate term. The incoming CEO brings MedTech leadership experience and returns TFX to its growth focus, but the company may face slower-than-expected adoption of key products, resulting in low-single digit growth and margin deterioration. In a downside scenario, the stock could reach $80 per share, while in the base case, the stock has a 12-month price target of $138.

Teleflex (TFX) has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 50% recommend Buy, 38% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 8 analysts, Teleflex (TFX) has a Buy consensus rating as of Jul 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $146.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $146.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.